Genital schistosomiasis and its unacknowledged role on HIV transmission in the STD intervention studies

International Journal of STD and AIDS

Volumn 25, Issue 10, 2014, Pages 705-715

  Kjetland, Eyrun F ^a,b,c   Hegertun, Ingrid Ea ^a   Baay, Marc Fd ^a,d   Onsrud, Mathias ^e   Ndhlovu, Patricia D ^f   Taylor, Myra ^b,c  

^a ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c UNIVERSITY OF KWAZULU NATAL   (South Africa)

^d UNIVERSITY OF ANTWERP   (Belgium)

^e OSLO UNIVERSITY HOSPITAL   (Norway)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

Author keywords

Female genital schistosomiasis; HIV incidence; Randomised controlled trial; RCT; Schistosomiasis; Sexually transmitted infections; Treatment; Women

Indexed keywords

ALBENDAZOLE; MEBENDAZOLE; ANTHELMINTIC AGENT;

ARTICLE; CD4+ T LYMPHOCYTE; CELL POPULATION; FEMALE GENITAL TRACT INFECTION; GENITAL SCHISTOSOMIASIS; GENITAL ULCER; HEALTH EDUCATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTERVENTION STUDY; MACROPHAGE; MONOCYTE; NONHUMAN; PRIORITY JOURNAL; PROSTITUTION; RANDOMIZED CONTROLLED TRIAL (TOPIC); RURAL AREA; SANITATION; SCHISTOSOMIASIS; SCHISTOSOMIASIS HAEMATOBIA; SCHISTOSOMIASIS MANSONI; SEASONAL VARIATION; SEXUALLY TRANSMITTED DISEASE; SYSTEMATIC REVIEW; VIRUS TRANSMISSION; ZIMBABWE; ADULT; ANIMAL; DISEASE TRANSMISSION; FEMALE; FEMALE GENITAL SCHISTOSOMIASIS; HIV INCIDENCE; ISOLATION AND PURIFICATION; PARASITOLOGY; RANDOMIZED CONTROLLED TRIAL; RCT; REVIEW; SCHISTOSOMA HEMATOBIUM; SEXUALLY TRANSMITTED INFECTIONS; TREATMENT;

FEMALE GENITAL SCHISTOSOMIASIS; HIV INCIDENCE; RANDOMISED CONTROLLED TRIAL; RCT; SCHISTOSOMIASIS; SEXUALLY TRANSMITTED INFECTIONS; TREATMENT; WOMEN;

ADULT; ANIMALS; ANTHELMINTICS; FEMALE; HIV INFECTIONS; HUMANS; INTERVENTION STUDIES; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SCHISTOSOMA HAEMATOBIUM; SCHISTOSOMIASIS HAEMATOBIA; SEXUALLY TRANSMITTED DISEASES;

EID: 84905913583     PISSN: 09564624     EISSN: 17581052     Source Type: Journal    
DOI: 10.1177/0956462414523743     Document Type: Article

References (115)

1. Grosskurth H, Mosha F, Todd J, et al. Impact of improved treatment of sexually transmitted diseases on HIV infection in rural Tanzania: randomised controlled trial. Lancet 1995; 346: 530–536.
2. Wawer MJ, Sewankambo NK, Serwadda D, et al. Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 1999; 353: 525–535.
3. Kamali A, Quigley M, Nakiyingi J, et al. Syndromic management of sexually-transmitted infections and behaviour change interventions on transmission of HIV-1 in rural Uganda: a community randomised trial. Lancet 2003; 361: 645–652.
4. Gregson S, Adamson S, Papaya S, et al. Impact and process evaluation of integrated community and clinic-based HIV-1 control: a cluster-randomised trial in eastern Zimbabwe. PLoS Med 2007; 4: e102.
5. Watson-Jones D, Weiss HA, Rusizoka M, et al. Effect of herpes simplex suppression on incidence of HIV among women in Tanzania. N Engl J Med 2008; 358: 1560–1571.
6. Celum C, Wald A, Hughes J, et al. Effect of aciclovir on HIV-1 acquisition in herpes simplex virus 2 seropositive women and men who have sex with men: a randomised, double-blind, placebo-controlled trial. Lancet 2008; 371: 2109–2119.
7. Ghys PD, Diallo MO, Ettiegne-Traore V, et al. Effect of interventions to control sexually transmitted disease on the incidence of HIV infection in female sex workers. AIDS 2001; 15: 1421–1431.
8. Kaul R, Kimani J, Nagelkerke NJ, et al. Monthly antibiotic chemoprophylaxis and incidence of sexually transmitted infections and HIV-1 infection in Kenyan sex workers: a randomized controlled trial. JAMA 2004; 291: 2555–2562.
9. Grosskurth H, Gray R, Hayes R, et al. Control of sexually transmitted diseases for HIV-1 prevention: understanding the implications of the Mwanza and Rakai trials. Lancet 2000; 355: 1981–1987.
10. White RG, Orroth KK, Korenromp EL, et al. Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study. J Acquir Immune Defic Syndr 2004; 37: 1500–1513.
11. Korenromp EL, White RG, Orroth KK, et al. Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: a synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 2005; 191: S168–S178.
12. Kjetland EF, Leutscher PD and Ndhlovu PD. A review of female genital schistosomiasis. Trends Parasitol 2012; 28: 58–65.
13. Leutscher PD, Ramarokoto CE, Hoffmann S, et al. Coexistence of urogenital schistosomiasis and sexually transmitted infection in women and men living in an area where Schistosoma haematobium is endemic. Clin Infect Dis 2008; 47: 775–782.
14. Swai B, Poggensee G, Mtweve S, et al. Female genital schistosomiasis as an evidence of a neglected cause for reproductive ill-health: a retrospective histopathological study from Tanzania. BMC Infect Dis 2006; 23: 134.
15. Ndeffo Mbah ML, Poolman EM, Drain PK, et al. HIV and Schistosoma haematobium prevalences correlate in sub-Saharan Africa. Tropical Med Int Health 2013; 18: 1174–1179.
16. Yirenya-Tawiah D, Amoah C, Apea-Kubi KA, et al. A survey of female genital schistosomiasis of the lower reproductive tract in the Volta Basin of Ghana. Ghana Med J 2011; 45: 16–21.
17. Hotez PJ, Fenwick A and Kjetland EF. Africa’s 32 cents solution for HIV/AIDS. PLoS Negl Trop Dis 2009; 3: e430.
18. Lillerud LE, Stuestoel VM, Hoel RE, et al. Exploring the feasibility and possible efficacy of mass treatment and education of young females as schistosomiasis influences the HIV epidemic. Arch Gynecol Obstet 2010; 281: 455–460.
19. King CH, Dickman K and Tisch DJ. Reassessment of the cost of chronic helmintic infection: a meta-analysis of disability-related outcomes in endemic schistosomiasis. Lancet 2005; 365: 1561–1569.
20. Madden F. A case of Bilharzia of the vagina. Lancet 1899; 1: 1716–1710.
21. Charlewood GP, Shippel S and Renton H. Schistosomiasis in gynaecology. J Obstet Gynaecol Br Emp 1949; 56: 367–385.
22. Berry A. A cytopathological and histopathological study of bilharziasis of the female genital tract. J Pathol Bacteriol 1966; 91: 325–338.
23. Gelfand M, Ross CM, Blair DM, et al. Schistosomiasis of the male pelvic organs. Severity of infection as determined by digestion of tissue and histologic methods in 300 cadavers. Am J Trop Med Hyg 1970; 19: 779–784.
24. Friedberg D and Schneider J. Gynaecological Bilharziasis. In: Charlewood GP (ed.) Gynaecology in Southern Africa. Johannesburg: Witwaterstrand University Press, 1972, pp.218–246.
25. WHO. Statement–WHO working group on urogenital schistosomiasis and HIV transmission. Geneva: WHO, 2009.
26. Renaud G, Devidas A, Develoux M, et al. Prevalence of vaginal schistosomiasis caused by Schistosoma haematobium in an endemic village in Niger. Trans R Soc Trop Med Hyg 1989; 83: 797.
27. Mbabazi PS, Andan O, Fitzgerald DW, et al. Examining the relationship between urogenital schistosomiasis and HIV infection. PLoS Negl Trop Dis 2011; 5: e1396.
28. Downs JA, Mguta C, Kaatano GM, et al. Urogenital schistosomiasis in women of reproductive age in Tanzania’s Lake Victoria region. Am J Trop Med Hyg 2011; 84: 364–369.
29. Kjetland EF, Ndhlovu PD, Gomo E, et al. Association between genital schistosomiasis and HIV in rural Zimbabwean women. AIDS 2006; 20: 593–600.
30. Kjetland EF, Kurewa EN, Ndhlovu PD, et al. Female genital schistosomiasis–a differential diagnosis to sexually transmitted disease: Genital itch and vaginal discharge as indicators of genital S. haematobium morbidity in a cross-sectional study in endemic rural Zimbabwe. Trop Med Int Health 2008; 13: 1509–1517.
31. Hegertun IE, Sulheim Gundersen KM, Kleppa E, et al. S. haematobium as a common cause of genital morbidity in girls: a cross-sectional study of children in South Africa. PLoS Negl Trop Dis 2013; 7: e2104.
32. Mosunjac MB, Tadros T, Beach R, et al. Cervical schistosomiasis, human papilloma virus (HPV), and human immunodeficiency virus (HIV): a dangerous coexistence or coincidence? Gynecol Oncol 2003; 90: 211–214.
33. Downs JA, van Dam GJ, Changalucha JM, et al. Association of Schistosomiasis and HIV infection in Tanzania. Am J Trop Med Hyg 2012; 87: 868–873.
34. Chenine AL, Shai-Kobiler E, Steele LN, et al. Acute Schistosoma mansoni infection increases susceptibility to systemic SHIV clade C infection in rhesus macaques after mucosal virus exposure. PLoS Negl Trop Dis 2008; 2: e265.
35. Leutscher PD, Pedersen M, Raharisolo C, et al. Increased prevalence of leukocytes and elevated cytokine levels in semen from Schistosoma haematobium-infected individuals. J Infect Dis 2005; 191: 1639–1647.
36. Leutscher PD, Ramarokoto CE, Reimert C, et al. Community-based study of genital schistosomiasis in men from Madagascar [letter]. Lancet 2000; 355: 117–118.
37. Leutscher PD, Reimert CM, Christensen NO, et al. Male genital schistosomiasis (MGS)–A neglected risk factor for HIV transmission in Sub-Saharan Africa? In: 13th International AIDS conference, Durban, South Africa, 2000, p.53 (abstract no. LbPeC7079).
38. Kjetland EF, Ndhlovu PD, Mduluza T, et al. Simple clinical manifestations of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg 2005; 72: 311–319.
39. Poggensee G, Kiwelu I, Saria M, et al. Schistosomiasis of the lower reproductive tract without egg excretion in urine. Am J Trop Med Hyg 1998; 59: 782–783.
40. Clements AC, Brooker S, Nyandindi U, et al. Bayesian spatial analysis of a national urinary schistosomiasis questionnaire to assist geographic targeting of schistosomiasis control in Tanzania, East Africa. Int J Parasitol 2008; 38: 401–415.
41. Kabatereine NB, Brooker S, Tukahebwa EM, et al. Epidemiology and geography of Schistosoma mansoni in Uganda: implications for planning control. Trop Med Int Health 2004; 9: 372–380.
42. Ndhlovu P, Chandiwana SK and Makura O. Progress in the control of schistosomiasis in Zimbabwe since 1984. Cent Afr J Med 1992; 38: 316–321.
43. Nkya WM, Shija DG and Mayala AP. Schistosoma haematobium: effect of non-schistosomicidal drugs (tetracycline and sulphadimidine) on schoolchildren. Trans R Soc Trop Med Hyg 1986; 80: 25–28.
44. Berge ST, Kabatereine NB, Gundersen SG, et al. Generic praziquantel in South Africa: The necessity for policy change to avail cheap, safe and efficacious schistosomiasis drugs to the poor, rural population. Southern Afr J Epidemiol Infect 2011; 26: 22–25.
45. Kjetland EF, Poggensee G, Helling-Giese G, et al. Female genital schistosomiasis due to Schistosoma haematobium. Clinical and parasitological findings in women in rural Malawi. Acta Trop 1996; 62: 239–255.
46. Jourdan PM, Randrianasolo BS, Feldmeier H, et al. Pathologic mucosal blood vessels in active female genital schistosomiasis: new aspects of a neglected tropical disease. Int J Gynecol Pathol 2013; 32: 137–140.
47. Jourdan PM, Roald B, Poggensee G, et al. Increased vascularity in cervicovaginal mucosa with Schistosoma haematobium infection. PLoS Negl Trop Dis 2011; 5: e1170.
48. Nmorsi O, Ukwandu N, Egwungenya O, et al. Evaluation of CD4(þ)/CD8(þ) status and urinary tract infections associated with urinary schistosomiasis among some rural Nigerians. Afr Health Sci 2005; 5: 126–130.
49. Smith J and Christie J. The pathobiology of Schistosoma haematobium infection in humans. Hum Pathol 1986; 17: 333–345.
50. Wright ED, Chiphangwi J and Hutt MS. Schistosomiasis of the female genital tract. A histopathological study of 176 cases from Malawi. Trans R Soc Trop Med Hyg 1982; 76: 822–829.
51. El-Shoura SM. Human Bilharzial ureters III. Fine structure of egg granuloma. Appl Parasitol 1993; 34: 265–273.
52. El-Shoura SM. Human Bilharzial ureters II. Cellular dynamic against deposited eggs. Ann Parasitol Hum Comp 1993; 68: 121–124.
53. Deelder AM, de Jonge N, Fillie YE, et al. Quantitative determination of circulating antigens in human schistosomiasis mansoni using an indirect hemagglutination assay. Am J Trop Med Hyg 1989; 40: 50–54.
54. Helling-Giese G, Sjaastad A, Poggensee G, et al. Female genital schistosomiasis (FGS): relationship between gynecological and histopathological findings. Acta Trop 1996; 62: 257–267.
55. Yeaman GR, Asin S, Weldon S, et al. Chemokine receptor expression in the human ectocervix: implications for infection by the human immunodeficiency virus-type I. Immunology 2004; 113: 524–533.
56. Hladik F, Sakchalathorn P, Ballweber L, et al. Initial events in establishing vaginal entry and infection by human immunodeficiency virus type-1. Immunity 2007; 26: 257–270.
57. Wu L. Biology of HIV mucosal transmission. Curr Opin HIV AIDS 2008; 3: 534–540.
58. Miller CJ and Shattock RJ. Target cells in vaginal HIV transmission. Microbes Infect 2003; 5: 59–67.
59. Miller CJ. HIV transmission: migratory Langerhans cells are primary targets in vaginal HIV transmission. Immunol Cell Biol 2007; 85: 269–270.
60. Fu CL, Odegaard JI, Herbert DR, et al. A novel mouse model of Schistosoma haematobium egg-induced immunopathology. PLoS Pathog 2012; 8: e1002605.
61. Jourdan PM, Holmen SD, Gundersen SG, et al. HIV target cells in Schistosoma haematobium-infected female genital mucosa. Am J Trop Med Hyg 2011; 85: 1060–1064.
62. Greenhead P, Hayes P, Watts PS, et al. Parameters of human immunodeficiency virus infection of human cervical tissue and inhibition by vaginal virucides. J Virol 2000; 74: 5577–5586.
63. Levine WC, Pope V, Bhoomkar A, et al. Increase in endocervical CD4 lymphocytes among women with nonulcerative sexually transmitted diseases. J Infect Dis 1998; 177: 167–174.
64. Sheffield JS, Wendel GD Jr, McIntire DD, et al. Effect of Genital Ulcer Disease on HIV-1 Coreceptor Expression in the Female Genital Tract. J Infect Dis 2007; 196: 1509–1516.
65. Schust DJ, Quayle AJ and Amedee AM. Mucosal coinfections and HIV-1 transmission and pathogenesis. Curr HIV Res 2012; 10: 195–201.
66. Secor WE, Shah A, Mwinzi PM, et al. Increased density of human immunodeficiency virus type 1 coreceptors CCR5 and CXCR4 on the surfaces of CD4(þ) T cells and monocytes of patients with Schistosoma mansoni infection. Infect Immun 2003; 71: 6668–6671.
67. Shapira-Nahor O, Kalinkovich A, Weisman Z, et al. Increased susceptibility to HIV-1 infection of peripheral blood mononuclear cells from chronically immune-activated individuals. AIDS 1998; 12: 1731–1733.
68. Gopinath R, Ostrowski M, Justement SJ, et al. Filarial infections increase susceptibility to human immunodeficiency virus infection in peripheral blood mononuclear cells in vitro. J Infect Dis 2000; 182: 1804–1808.
69. Secor WE, Karanja DM and Colley DG. Interactions between Schistosomiasis and human immunodeficiency virus in Western Kenya. Mem Inst Oswaldo Cruz 2004; 99: 93–95.
70. Shapira-Nahor O, Maayan S, Peden KW, et al. Replication of HIV-1 deleted Nef mutants in chronically immune activated human T cells. Virology 2002; 303: 138–145.
71. Taylor JJ, Mohrs M and Pearce EJ. Regulatory T cell responses develop in parallel to Th responses and control the magnitude and phenotype of the Th effector population. J Immunol 2006; 176: 5839–5847.
72. Borkow G and Bentwich Z. HIV and helminth co-infection: is deworming necessary? Parasite Immunol 2006; 28: 605–612.
73. Brooker S, Hay SI, Issae W, et al. Predicting the distribution of urinary schistosomiasis in Tanzania using satellite sensor data. Trop Med Int Health 2001; 6: 998–1007.
74. Stothard JR. Improving control of African schistosomiasis: towards effective use of rapid diagnostic tests within an appropriate disease surveillance model. Trans R Soc Trop Med Hyg 2009; 103: 325–332.
75. WHO. Schistosomiasis progress report 2001–2011 and strategic plan 2012–2020. 2013.
76. Appleton CC, Maurihungirire M and Gouws E. The distribution of helminth infections along the coastal plain of Kwazulu-Natal province, South Africa. Ann Trop Med Parasitol 1999; 93: 859–868.
77. Kloos H and David R. The paleoepidemiology of schistosomiasis in ancient Egypt. Res Human Ecol 2002; 9: 14–25.
78. Chandiwana SK and Woolhouse ME. Heterogeneities in water contact patterns and the epidemiology of Schistosoma haematobium. Parasitology 1991; 103: 363–370.
79. Ahmed ES, Daffalla A, Christensen NO, et al. Patterns of infection and transmission of human schistosomiasis mansoni and schistosomiasis haematobium in White Nile Province, Sudan. Ann Trop Med Parasitol 1996; 90: 173–180.
80. Brooker S, Alexander N, Geiger S, et al. Contrasting patterns in the small-scale heterogeneity of human helminth infections in urban and rural environments in Brazil. Int J Parasitol 2006; 36: 1143–1151.
81. Chandiwana SK, Christensen NO and Frandsen F. Seasonal patterns in the transmission of Schistosoma haematobium, S. mattheei and S. mansoni in the highveld region of Zimbabwe. Acta Trop 1987; 44: 433–444.
82. Kvalsvig JD and Schutte CH. The role of human water contact patterns in the transmission of schistosomiasis in an informal settlement near a major industrial area. Ann Trop Med Parasitol 1986; 80: 13–26.
83. Sharfi AR and Hassan O. Evaluation of haematuria in Khartoum. East Afr Med J 1994; 71: 29–31.
84. Firmo JO, Lima Costa MF, Guerra HL, et al. Urban schistosomiasis: morbidity, sociodemographic characteristics and water contact patterns predictive of infection. Int J Epidemiol 1996; 25: 1292–300.
85. Ernould JC, Kaman A, Labbo R, et al. Recent urban growth and urinary schistosomiasis in Niamey, Niger. Trop Med Int Health 2000; 5: 431–437.
86. Johnson CL and Appleton CC. Urban schistosomiasis transmission in Pietermaritzburg, South Africa. Southern Afr J Epidemiol Infect 2005; 20: 103–107.
87. Agbolade OM, Agu NC, Adesanya OO, et al. Intestinal helminthiases and schistosomiasis among school children in an urban center and some rural communities in southwest Nigeria. Korean J Parasitol 2007; 45: 233–238.
88. Kloos H, Correa-Oliveira R, dos Reis DC, et al. The role of population movement in the epidemiology and control of schistosomiasis in Brazil: a preliminary typology of population movement. Mem Inst Oswaldo Cruz 2010; 105: 578–586.
89. Kriitmaa K, Testa A, Osman M, et al. HIV prevalence and characteristics of sex work among female sex workers in Hargeisa, Somaliland, Somalia. AIDS 2010; 24: S61–S67.
90. UNAIDS. Report on the global HIV/AIDS epidemic. Geneva: Joint United Nations Programme on HIV/AIDS (UNAIDS), 2002, pp.114–119.
91. Serwadda D, Wawer MJ, Musgrave SD, et al. HIV risk factors in three geographic strata of rural Rakai District, Uganda. AIDS 1992; 6: 983–989.
92. Barongo L, Borgdorff MW, Mosha FF, et al. The epidemiology of HIV-1 infection in urban areas roadside settlements and rural villages in Mwanza Region, Tanzania. AIDS 1992; 6: 1521–1528.
93. Ndamba J, Chidimu MG, Zimba M, et al. An investigation of the schistosomiasis transmission status in Harare. Cent Afr J Med 1994; 40: 337–342.
94. UNFPA. State of world population. Unleashing the potential of urban growth. New York: United Nations Population Fund, 2007.
95. Hayes R, Watson-Jones D, Celum C, et al. Treatment of sexually transmitted infections for HIV prevention: end of the road or new beginning? AIDS 2010; 24: S15–S26.
96. Nazerali H and Levy L. Essential drugs list and standard treatment guidelines for Zimbabwe. EDLIZ. Harare, Zimbabwe: Ministry of Health and Child Welfare, 1994.
97. EDLIZ. 4th essential drugs list and standard treatment guidelines for Zimbabwe. EDLIZ. Harare, Zimbabwe: Ministry of Health and Child Welfare, 2000.
98. Moffatt J. Essential drugs list and standard treatment guidelines for Zimbabwe. EDLIZ. Harare, Zimbabwe: NDTPAC Publishing, 1985, pp.50–51.
99. Danso-Appiah A, Utzinger J, Liu J, et al. Drugs for treating urinary schistosomiasis. Cochrane Database Syst Rev 2008; 16: CD000053.
100. Al-Waili NS. Mebendazole in the treatment of Schistosoma haematobium. Trans R Soc Trop Med Hyg 1987; 81:781.
101. Nessim NG, Hassan SI, William S, et al. Effect of the broad spectrum antihelmintic drug flubendazole upon Schistosoma mansoni experimentally infected mice. Arzneimittelforschung 2000; 50: 1129–1133.
102. Mkhize-Kwitshana ZL, Taylor M, Jooste P, et al. The influence of different helminth infection phenotypes on immune responses against HIV in co-infected adults in South Africa. BMC Infect Dis 2011; 11: 273.
103. Knopp S, Mohammed KA, Ali SM, et al. Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach. BMC Public Health 2012; 12:930.
104. Gray RH and Wawer MJ. Reassessing the hypothesis on STI control for HIV prevention. Lancet 2008; 371: 2064–2065.
105. Kjetland EF, Ndhlovu PD, Kurewa EN, et al. Prevention of gynecologic contact bleeding and genital sandy patches by childhood anti-schistosomal treatment. Am J Tropic Med Hyg 2008; 79: 79–83.
106. Fulford AJ, Butterworth AE, Sturrock RF, et al. On the use of age-intensity data to detect immunity to parasitic infections, with special reference to Schistosoma mansoni in Kenya. Parasitology 1992; 105: 219–227.
107. Ndhlovu P, Cadman H, Vennervald BJ, et al. Agerelated antibody profiles in Schistosoma haematobium infections in a rural community in Zimbabwe. Parasite Immunol 1996; 18: 181–191.
108. Ndhlovu PD, Mduluza T, Kjetland EF, et al. Prevalence of urinary schistosomiasis and HIV in females living in a rural community of Zimbabwe: does age matter? Trans R Soc Trop Med Hyg 2007; 101: 433–438.
109. Koukounari A, Webster JP, Donnelly CA, et al. Sensitivities and specificities of diagnostic tests and infection prevalence of Schistosoma haematobium estimated from data on adults in villages northwest of Accra, Ghana. Am J Trop Med Hyg 2009; 80: 435–441.
110. ten Hove R, Verweij J, Vereecken K, et al. Multiplex real-time PCR for the detection and quantification of Schistosoma mansoni and S. haematobium infection in stool samples collected in northern Senegal. Trans R Soc Trop Med Hyg 2008; 102: 179–185.
111. Kjetland EF, ten Hove RJ, Gomo E, et al. Schistosomiasis PCR in vaginal lavage as an indicator of genital Schistosoma haematobium infection in rural Zimbabwean women. Am J Trop Med Hyg 2009; 81: 1050–1055.
112. Poggensee G, Kiwelu I, Weger V, et al. Female genital schistosomiasis of the lower genital tract: prevalence and disease-associated morbidity in Northern Tanzania. J Infect Dis 2000; 181: 1210–1213.
113. Basuni M, Muhi J, Othman N, et al. A pentaplex realtime polymerase chain reaction assay for detection of four species of soil-transmitted helminths. Am J Trop Med Hyg 2011; 84: 338–343.
114. Lessing C. Essential drugs list and standard treatment guidelines for Zimbabwe. EDLIZ. Harare, Zimbabwe: NDTPAC Publishing, 1998.
115. Matthys B, Tschannen AB and Tian-Bi NT. Risk factors for Schistosoma mansoni and hookworm in urban farming communities in western Cote d’Ivoire. Trop Med Int Health 2007; 12: 709–723.